Aloul, K. M., Nielsen, J. E., Defensor, E. B., Lin, J. S., Fortkort, J. A., Shamloo, M., . . . Barron, A. E. (2022). Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Frontiers in immunology, 13, 880961. https://doi.org/10.3389/fimmu.2022.880961
Citace podle Chicago (17th ed.)Aloul, Karim M., Josefine Eilsø Nielsen, Erwin B. Defensor, Jennifer S. Lin, John A. Fortkort, Mehrdad Shamloo, Jeffrey D. Cirillo, Adrian F. Gombart, a Annelise E. Barron. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology 13 (2022): 880961. https://doi.org/10.3389/fimmu.2022.880961.
Citace podle MLA (9th ed.)Aloul, Karim M., et al. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology, vol. 13, 2022, p. 880961, https://doi.org/10.3389/fimmu.2022.880961.